The table below shows ATAI Life Sciences N.V.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$17.84M
-$22.57M
-$21.11M
-$23.99M
-$16.52M
Capital expenditure
$268.00K
$0.00
$280.00K
$56.00K
$175.00K
Investing cash flow
-$11.01M
$11.47M
$16.02M
-$214.74M
-$3.72M
Dividends paid
-
-
-
-
-
Stock buybacks
-
-
ATAI operating cash flow (10-K history)
ATAI Life Sciences N.V. reported operating cash flow of -$82.44M for fiscal year 2024. That is up 2.0% from -$84.12M in fiscal 2023. Over the 5 fiscal years shown, operating cash flow declined from -$20.77M (FY 2020) to -$82.44M. Figures come from the company's audited annual reports as filed with the SEC.